Subimerb Chutima, Pinlaor Somchai, Khuntikeo Narong, Leelayuwat Chanvit, Morris Alanna, McGrath Michael S, Wongkham Sopit
Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Mol Med Rep. 2010 Jul-Aug;3(4):597-605. doi: 10.3892/mmr_00000303.
Cholangiocarcinoma (CCA) is a high metastatic cancer with no effective treatment. Here, the pro-metastatic action of tissue macrophages in CCA is demonstrated and suggested as a prognostic marker and novel target for the therapeutic intervention of CCA. Fifty CCA tissues were immunohistochemically stained with a marker for reactive/infiltrating monocytes/macrophages (MAC387) and matrix metalloproteinase (MMP)-9. The antigenic densities in positively-stained cells along the leading edge of tumors were scored. Correlations between the densities of MAC387, MMP-9-positive cells, clinicopathological features and patient survival were investigated. High densities of MAC387-positive cells were detected in more than 60% of the CCA tissues. This was significantly associated with poor prognosis parameters (non-papillary and mass-forming type CCA). Overall survival was worst in patients with high-density MAC387-positive cells. Double immunofluorescent staining indicated that MAC387-positive cells co-expressed MMP-9. Immunohistochemical staining of MMP-9 in serial sections of CCA tissues indicated that MMP-9 was rarely expressed in CCA tumor cells, but highly expressed in MAC387-positive cells and polymorphonucleated infiltrating cells. Patients with high tissue expression levels of MAC387 in combination with MMP-9-expressing cells had the worst survival. These factors were found to be independent predictors of the post-resectional survival of CCA patients. Since CCA tumor cells rarely expressed MMP-9, it is likely that tissue macrophages are critical for degrading the extracellular matrix and for facilitating tumor metastasis. They may therefore serve as a prognostic marker for poor clinical outcome, and represent novel targets for the therapeutic intervention of CCA.
胆管癌(CCA)是一种高转移性癌症,目前尚无有效治疗方法。在此,我们证实了组织巨噬细胞在CCA中的促转移作用,并建议将其作为CCA治疗干预的预后标志物和新靶点。对50例CCA组织进行免疫组织化学染色,使用反应性/浸润性单核细胞/巨噬细胞标志物(MAC387)和基质金属蛋白酶(MMP)-9。对肿瘤前缘阳性染色细胞的抗原密度进行评分。研究了MAC387、MMP-9阳性细胞密度、临床病理特征与患者生存率之间的相关性。在超过60%的CCA组织中检测到高密度的MAC387阳性细胞。这与不良预后参数(非乳头状和肿块形成型CCA)显著相关。MAC387阳性细胞密度高的患者总生存期最差。双重免疫荧光染色表明MAC387阳性细胞共表达MMP-9。CCA组织连续切片中MMP-9的免疫组织化学染色表明,MMP-9在CCA肿瘤细胞中很少表达,但在MAC387阳性细胞和多形核浸润细胞中高表达。MAC387组织表达水平高且伴有MMP-9表达细胞的患者生存期最差。这些因素被发现是CCA患者切除术后生存的独立预测因素。由于CCA肿瘤细胞很少表达MMP-9,组织巨噬细胞可能对降解细胞外基质和促进肿瘤转移至关重要。因此,它们可能作为临床预后不良的预后标志物,并代表CCA治疗干预的新靶点。